Editöre Mektup
BibTex RIS Kaynak Göster

Antimikrobiyal dirence karşı koymak için insan merkezli yaklaşımı savunmak

Yıl 2024, Cilt: 49 Sayı: 3, 855 - 857, 30.09.2024
https://doi.org/10.17826/cumj.1379986

Öz

Antimikrobiyal dirençle mücadelede insan merkezli müdahalelerin önemi yadsınamaz. Antimikrobiyal direncin kontrol altına alınması çok yönlü bir yaklaşım gerektirecektir ve bu yaklaşımın merkezinde halk yer almaktadır. Yönetişimin güçlendirilmesi, sürveyansın genişletilmesi, araştırmaların teşvik edilmesi ve ilaca dirençli enfeksiyonların önlenmesi, teşhisi ve yönetiminin yaygınlaştırılması günün ihtiyacıdır.

Kaynakça

  • WHO. Antimicrobial Resistance: Key Facts. Geneva, World Health Organization, 2021..
  • Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109:309-18.
  • World Health Organization. People-Centred Approach to Addressing Antimicrobial Resistance in Human Health: WHO Core Package of Interventions to Support National Action Plans. Geneva, WHO, 2022;5-27.
  • Rice LB. Antimicrobial stewardship and antimicrobial resistance. Med Clin North Am. 2018;102:805-18.
  • Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399:629-55.
  • Howard SJ, Hopwood S, Davies SC. Antimicrobial resistance: A global challenge. Sci Transl Med. 2014;6:236ed10.
  • Wallmann J. Antimicrobial resistance: Challenges ahead. Vet Rec. 2014;175:323-4.
  • Sugden R, Kelly R, Davies S. Combatting antimicrobial resistance globally. Nat Microbiol. 2016;1:16187.
  • Burch D. Transmission of antimicrobial resistance from animals to people. Vet Rec. 2016;179:51-2.
  • Tillotson G. Antimicrobial resistance: what's needed. Lancet Infect Dis. 2015;15:758-60.
  • Walia K, Ohri VC. Strengthening surveillance key to addressing antimicrobial resistance. Indian J Med Microbiol. 2016;34:413-5.
  • Tacconelli E, Sifakis F, Harbarth S, Schrijver R, van Mourik M, Voss A et al. Surveillance for control of antimicrobial resistance. Lancet Infect Dis. 2018;18:e99-.e106.
  • Head MG, Fitchett JR, Atun R. Investing in antimicrobial resistance research. Br J Hosp Med (Lond). 2014;75:6-7.
  • Rosini R, Nicchi S, Pizza M, Rappuoli R. Vaccines against antimicrobial resistance. Front Immunol. 2020;11:1048.
  • Watkins RR, Bonomo RA. Overview: The ongoing threat of antimicrobial resistance. Infect Dis Clin North Am 2020;34:649-58

Advocating people-centered approach to counter antimicrobial resistance

Yıl 2024, Cilt: 49 Sayı: 3, 855 - 857, 30.09.2024
https://doi.org/10.17826/cumj.1379986

Öz

The significance of people-centered interventions in to fight against antimicrobial resistance cannot be overstated. The containment of antimicrobial resistance will require a multifaceted approach, and in this general public occupies the center stage. The need of the hour is to strengthen governance, expand surveillance, promote research, and expand prevention, diagnosis, and management of drug-resistant infections.

Etik Beyan

Nil

Destekleyen Kurum

None

Teşekkür

Nil

Kaynakça

  • WHO. Antimicrobial Resistance: Key Facts. Geneva, World Health Organization, 2021..
  • Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109:309-18.
  • World Health Organization. People-Centred Approach to Addressing Antimicrobial Resistance in Human Health: WHO Core Package of Interventions to Support National Action Plans. Geneva, WHO, 2022;5-27.
  • Rice LB. Antimicrobial stewardship and antimicrobial resistance. Med Clin North Am. 2018;102:805-18.
  • Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399:629-55.
  • Howard SJ, Hopwood S, Davies SC. Antimicrobial resistance: A global challenge. Sci Transl Med. 2014;6:236ed10.
  • Wallmann J. Antimicrobial resistance: Challenges ahead. Vet Rec. 2014;175:323-4.
  • Sugden R, Kelly R, Davies S. Combatting antimicrobial resistance globally. Nat Microbiol. 2016;1:16187.
  • Burch D. Transmission of antimicrobial resistance from animals to people. Vet Rec. 2016;179:51-2.
  • Tillotson G. Antimicrobial resistance: what's needed. Lancet Infect Dis. 2015;15:758-60.
  • Walia K, Ohri VC. Strengthening surveillance key to addressing antimicrobial resistance. Indian J Med Microbiol. 2016;34:413-5.
  • Tacconelli E, Sifakis F, Harbarth S, Schrijver R, van Mourik M, Voss A et al. Surveillance for control of antimicrobial resistance. Lancet Infect Dis. 2018;18:e99-.e106.
  • Head MG, Fitchett JR, Atun R. Investing in antimicrobial resistance research. Br J Hosp Med (Lond). 2014;75:6-7.
  • Rosini R, Nicchi S, Pizza M, Rappuoli R. Vaccines against antimicrobial resistance. Front Immunol. 2020;11:1048.
  • Watkins RR, Bonomo RA. Overview: The ongoing threat of antimicrobial resistance. Infect Dis Clin North Am 2020;34:649-58
Toplam 15 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Bulaşıcı Hastalıklar
Bölüm Editöre Mektup
Yazarlar

Saurabh Shrivastava 0000-0001-6102-7475

Prateek Shrivastava 0000-0001-5290-6312

Yayımlanma Tarihi 30 Eylül 2024
Gönderilme Tarihi 23 Ekim 2023
Kabul Tarihi 25 Aralık 2023
Yayımlandığı Sayı Yıl 2024 Cilt: 49 Sayı: 3

Kaynak Göster

MLA Shrivastava, Saurabh ve Prateek Shrivastava. “Advocating People-Centered Approach to Counter Antimicrobial Resistance”. Cukurova Medical Journal, c. 49, sy. 3, 2024, ss. 855-7, doi:10.17826/cumj.1379986.